404
Left Atrial Appendage Closure Devices Market Analysis | 2023-2028
Left Atrial Appendage Closure Devices Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
Left Atrial Appendage Closure Devices Market is segmented by Product Type (Endocardial LAA Closure Devices, Epicardial LAA Closure Devices), by Procedure Type (Percutaneous, Surgical), by End-Use Type (Hospitals, Ambulatory Surgical Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Left atrial appendage closure is a technique that assists in lowering the risk of stroke. It (LAA) is a small-sized, ear-shaped sac sited in the muscle wall of the left atrium. Left atrial appendage closure devices are used to reduce the possibility of blood clots, thus preventing stroke. They are implantable cardiac devices that are placed in the left atrial appendage for the prevention of stroke in patients.
The left atrial appendage closure devices market was estimated at USD 1.25 billion in 2022.
The left atrial appendage closure devices market is likely to reach USD 3.8 billion in 2028.
The left atrial appendage closure devices market is likely to grow at a CAGR of 20.27% during 2023-2028.
Abbott Laboratories, Aegis Medical Group, AtriCure Inc., Boston Scientific Corporation, Coherex Medical Inc., Dune Medical Devices, Johnson & Johnson Services, Inc., Lifetech Scientific, Cardia, Inc., Occlutech International AB, and St. Jude Medical, Inc. are among the key players in the market.
North America is expected to be the fastest-growing market.
The epicardial left atrial appendage closure device segment is expected to grow at a higher CAGR in the market.